Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Liver Regeneration in Live Donors
NCT07085806Recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of pentoxifylline in post-hepatectomy liver failure (PHLF) (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Anatomical (Volume) Regeneration of liver at 2 weeks. Started Jan 2025; status: recruiting.
02
Drugs
pentoxifylline
03
Conditions
post-hepatectomy liver failure (PHLF)
Beyond the preview
Go deeper on NCT07085806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07085806.